However, there are usually some warning signs before the API supply chain disruption occurs. Manufacturing-related, regulatory, shortage of raw materials, logistics, manufacturing capacity and dependency on supplier issues can be a signal of something going wrong.

The key here is spotting these warning signals ahead of time before they start affecting production.

Why API Supply Chain Intelligence is Important

Using API supply chain intelligence, procurement teams can spot possible risks sooner and develop alternative solutions.

What Is API Supply Chain Intelligence?

API supply chain intelligence involves collecting and analyzing information about API producers, suppliers, products, regulatory status, market situation, places of manufacturing, and dependencies of the supply chain.

Unlike simple list of API suppliers globally, an intelligence-based system provides more detailed data allowing procurement teams to understand:

• Who manufactures a particular API
• Where the manufacturing facilities are located
• Which markets the supplier serves
• What regulatory information is available
• Whether alternative manufacturers exist
• How market conditions may affect supply
• Risks associated with supplier concentration

The above information enables the procurement and supply chain team to have an understanding of the sourcing environment.

1. Identifying Single-Supplier and Geographic Dependency

Being overly dependent on one supplier or region could put a company’s supply chain at risk. In the event of a problem with the supplier, such as delays in production, quality problems, compliance issues, or shortages in raw materials, it might be difficult to replace the supplier.

A list of Top Pharmaceutical API Suppliers could aid procurement departments in recognizing other manufacturers that manufacture the same API. A comparison of the suppliers in various locations could enable the organization to find out if there is over-reliance on one supplier or location.

For instance, a pharmaceutical firm that relies on one supplier for its important API could encounter production delays when the supplier halts production for some time.

Procurement teams should review:

• Number of available manufacturers
• Manufacturing country and region
• Production site locations
• Product and molecule coverage
• Supplier capacity indicators
• Availability of alternative sources

Supplier diversification should not entail including unvetted suppliers. Each and every alternative must go through a rigorous evaluation process that includes technical, quality, regulatory, and commercial considerations.

2. Evaluating the Risks Associated with Manufacturing and Capacity

The availability of an API can be jeopardized by maintenance activities in plants, machine breakdowns, production stoppages, shortage of raw materials, labor problems, or inadequate manufacturing capacity.

A worldwide api supplier database can assist in evaluating the capabilities of suppliers and their manufacturing process information prior to making any decisions on procurement.Important information to monitor includes:

• Manufacturing capabilities
• Production locations
• API portfolio
• Manufacturing site changes
• Lead times
• Minimum order quantities
• Raw material dependencies
• Capacity-related announcements
• Changes in supplier activity

The company may seem like a great supplier because of the availability of products, but it may not be capable of handling the necessary volume and schedule of deliveries. The early review of manufacturing details will help determine this situation.

3. Detecting Regulatory and Quality-Related Risks

Regulatory and quality issues can interrupt API supply and create serious consequences for pharmaceutical manufacturers. Problems related to GMP compliance, manufacturing documentation, inspections, or regulatory filings may affect a supplier’s ability to serve specific markets.

An API sourcing Database can support preliminary regulatory and quality screening by providing information related to:

• GMP status
• Manufacturing site details
• DMF availability
• Regulatory approvals
• Inspection-related information
• Product documentation
• Regulatory filing status
• Changes in manufacturing locations or processes

The World Health Organization’s API prequalification process includes an assessment of API quality information and inspection of manufacturing sites for compliance with WHO GMP requirements. This highlights the importance of reviewing both product information and manufacturing-site compliance when assessing API sources.

However, database information should not be treated as final supplier approval. Procurement and quality teams must independently verify documentation, review specifications, conduct audits where required, and complete formal qualification procedures.

4. Understanding Market and Pricing Risks

Changes in the market situation occur rapidly. They include changes in demand, changes in raw material cost, production issues, export restrictions, and supplier competition. Buyers may become aware of such factors only after making a request for a quote or placing an order.

In the absence of market insight, the above factors may result in increased costs, longer lead times, and restricted negotiations. The database will provide the buyer with the opportunity to compare various market and supplier factors, such as:

• Supplier pricing patterns
• Regional market conditions
• Product availability
• Historical market movements
• Minimum order quantities
• Lead times
• Alternative manufacturers
• Demand and supply trends

As an illustration, when demand for a certain API rises, procurement teams having access to market intelligence can start looking for other vendors while prices are still reasonable and there is sufficient availability. Price benchmarking should always take into consideration parameters like the size of the order, quality, manufacturing country, transportation, delivery time, and so on. A cheaper quote does not mean necessarily the better one if it involves higher lead time and qualification risk.

5. Finding Alternative Suppliers Before a Disruption

Searching for an alternative supplier after production has already been affected can create unnecessary pressure. Procurement teams may have limited time to compare companies, request documents, evaluate samples, and complete qualification activities.

A global api supplier list can support initial supplier discovery, while a detailed Top Pharmaceutical API Suppliers database can help teams narrow the list based on more relevant criteria.

Potential alternative suppliers can be evaluated according to:

• API manufacturing capability
• Geographic location
• Regulatory market coverage
• DMF or technical documentation
• Production capacity
• Product grade
• Commercial terms
• Export experience
• Supply history
• Quality and compliance information

Maintaining a list of potential alternatives allows procurement teams to prepare a second-source strategy for critical APIs. It also supports better planning when demand increases or an existing supplier becomes unavailable.

The Value of API Supply Chain Intelligence for Improved Planning

An intelligence methodology could assist the procurement department to transition from reactive sourcing to proactive risk management.

A practical workflow may include:

1. Identify critical APIs and high-risk products.
2. Map current suppliers and manufacturing locations.
3. Review supplier capabilities and regulatory information.
4. Evaluate dependencies in terms of geographic location and single source.
5. Observe market and pricing trends.
6. Review other options.
7. Share findings with the purchasing, quality control, and regulatory experts.
8. Review the sourcing strategy as necessary based on new information.

Chemxpert Database helps to do this by providing product intelligence, company intelligence, sourcing intelligence, regulatory intelligence, and market intelligence.

Conclusion

Some of the API supply chain risks that can impact pharmaceutical manufacturing include dependency on suppliers, manufacturing risks, regulatory issues, market dynamics, and scarcity of alternative suppliers.

Though a basic world-wide api supplier list will be useful for identifying manufacturers, a well-researched intelligence-based Api sourcing Database can give more insights into understanding potential risks.

With the help of intelligence related to API supply chain, procurement teams will be able to assess supplier concentration risk, manufacturing and regulatory risks, market dynamics, and possible alternative suppliers.

It is not an alternative to supplier qualification process; rather, it offers procurement, quality, regulatory, and supply chain teams the necessary information for making informed decisions.

FAQs

1. What is API supply chain intelligence?

API supply chain intelligence is an analysis of the supplier, manufacturing, regulation, product and market information to determine any risks involved in sourcing APIs.

2. How does an API database help in reducing supply chain risks?

An API database enables procurement teams to identify their supplier dependencies, check manufacturing information, assess regulatory risks, and source alternative API manufacturers.

3. What is the distinction between an international API supplier list and an API sourcing database?

The list of suppliers only contains information about the supplier's name and contact details, whereas the database of API sourcing provides additional details about the supplier's capabilities and production facilities.

4. Is API sourcing intelligence a substitute for supplier qualification?

Not necessarily. This intelligence will help in performing some preliminary research and risk assessment but the qualification itself is still necessary.

4.    Why do pharmaceutical companies need to discover alternative API suppliers early?

Identification of alternative sources gives sufficient time to assess and onboard the new sources before the disruption occurs.